Madopar 250
Madopar 250 is a medicine authorised by Swissmedic under authorisation number 43593. The authorisation holder is Roche Pharma (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 27 January 1981 and the authorisation is valid without a time limit. ATC code N04BA02 places the medicine in the group Anti-Parkinson drugs.
| Authorisation number | 43593 |
|---|---|
| Name | Madopar 250 |
| Full name | Madopar 250, Tabletten |
| Authorisation holder | Roche Pharma (Schweiz) AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N04BA02 |
| First authorisation | 27 January 1981 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Madopar 250, Tabletten | B | 27 January 1981 |
| 2 | Madopar 125, Tabletten | B | 20 May 1987 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 13 | 30 | Tablette(n) | N04BA02 | 01.08.0. | B |
| 21 | 100 | Tablette(n) | N04BA02 | 01.08.0. | B |
| 48 | 30 | Tablette(n) | N04BA02 | 01.08.0. | B |
| 56 | 100 | Tablette(n) | N04BA02 | 01.08.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Madopar 250 authorised in Switzerland?
Yes. Madopar 250 is authorised by Swissmedic under authorisation number 43593, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Madopar 250 have?
Madopar 250 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Madopar 250?
The authorisation holder is Roche Pharma (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.